NIH researchers isolate effective COVID-19 nanobody

By The Science Advisory Board staff writers

December 22, 2020 -- It is possible to treat COVID-19 successfully using nanobodies -- tiny antibodies -- derived from llamas, and one effective nanobody has been identified, researchers affiliated with the U.S. National Institutes of Health (NIH) reported in Scientific Reports online December 22.

Experience with nanobodies taken from a llama named Cormac suggest the potential to prevent infections and prevent the transmission of the virus, Dr. David Brody, PhD, director of the Center for Neuroscience and Regenerative Medicine at the Uniformed Services University of the Health Sciences in Bethesda, Md, reported.

One nanobody, dubbed as NIH-CoVnb-112, worked in liquid and aerosol forms and was effective after inhalation, researchers reported. Low levels of the NIH-CoVnb-112 nanobodies prevented infection in in vitro studies, they reported.


Copyright © 2020 scienceboard.net
 


Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

 
I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.